FDA Allows Emergency Use Of Gilead Drug For COVID-19
The U.S. Food and Drug Administration on Friday gave the green light to Gilead's experimental antiviral drug remdesivir for treatment of COVID-19 patients, issuing an emergency use authorization that noted the...To view the full article, register now.
Already a subscriber? Click here to view full article